logo-loader
ASX:BD1

Bard1 Life Sciences Ltd

Receive alerts
Market:
ASX
Market Cap:
$41.02 m
Price
$0.03
Change
0.00%
52 weeks high
0.07
52 weeks low
0.01

Viewing results 1-8 of 8

Health

BARD1 Life Sciences develops world's first blood test for early detection of breast cancer

BARD1 breast cancer test accurately distinguishes malignant breast cancer from benign lesions....

on 23/10/18
Health

BARD1 Life Sciences signs agreement to develop custom research assay

The company’s proprietary platform, BARD1, is based on novel tumour markers with potential diagnostic applications....

on 18/5/18
Health

BARD1 Life Sciences secures Israeli patent for unique lung cancer test

Lung cancer is the leading cause of cancer death in Australia....

on 21/3/18
Health

Bard1 Life Sciences is one of the ASX’s most active top performers today

The company is developing a non-invasive diagnostic test for ovarian cancer....

on 8/3/18
Health

BARD1 Life Sciences Ltd raising funds for novel cancer diagnostics

The company is developing diagnostic tests for early detection of cancer....

on 5/7/17
Health

BARD1 Life Sciences Ltd targets cash injection

The halt will remain in place until Wednesday 5th July 2017....

on 3/7/17
Health

BARD1 Life Sciences shares surge after positive ovarian cancer test

The BARD1 ovarian cancer test is an ELISA-based blood test....

on 23/3/17